100 related articles for article (PubMed ID: 7768064)
21. [Relationship between lipoprotein A, apolipoprotein A and their isoforms in parents and children].
Ferrer Lorente B; Dalmau Serra J; Falcó Couchoud C; Estellés Cortés A; España Furió F; Aznar Lucea J
An Esp Pediatr; 1998 Jun; 48(6):587-92. PubMed ID: 9662841
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
Emanuele E; Peros E; Tomaino C; Feudatari E; Bernardi L; Binetti G; Maletta R; D'Angelo A; Montagna L; Bruni AC; Geroldi D
Neurosci Lett; 2004 Feb; 357(1):45-8. PubMed ID: 15036610
[TBL] [Abstract][Full Text] [Related]
23. Gender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjects.
Topic A; Spasojevic Kalimanovska V; Zeljkovic A; Vekic J; Jelic Ivanovic Z
Clin Biochem; 2008 Apr; 41(6):361-7. PubMed ID: 18086568
[TBL] [Abstract][Full Text] [Related]
24. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
25. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
26. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.
Ribault A; Durou MR; Letellier C; Wojcik F; Poirier JY; Ruelland A
Diabetes Metab; 2000 Apr; 26(2):107-12. PubMed ID: 10804324
[TBL] [Abstract][Full Text] [Related]
27. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
Kalina A ; Császár A; Füst G; Nagy B; Szalai C; Karádi I; Duba J; Prohászka Z; Horváth L; Dieplinger H
Clin Chim Acta; 2001 Jul; 309(1):45-51. PubMed ID: 11408005
[TBL] [Abstract][Full Text] [Related]
28. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
[TBL] [Abstract][Full Text] [Related]
29. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
[TBL] [Abstract][Full Text] [Related]
30. [Significance of cholesterol as a risk factor in children and adolescents].
Elcarte López R; Gasco Eguiluz M
An Esp Pediatr; 1991 Dec; 35 Suppl 46():176-9. PubMed ID: 1821537
[TBL] [Abstract][Full Text] [Related]
31. Determination of free apolipoprotein(a) in serum by immunoassay and its significance for risk assessment in patients with coronary artery disease.
Herrmann W; Quast S; Wolter K; Eger H; Kiessig ST; Hahmann H; Kreuter J; Molinari E
Clin Chem Lab Med; 1999 Jan; 37(1):21-8. PubMed ID: 10094374
[TBL] [Abstract][Full Text] [Related]
32. Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease.
Katsouras CS; Karabina SA; Tambaki AP; Goudevenos JA; Michalis LK; Tsironis LD; Stroumbis CS; Elisaf MS; Sideris DA; Tselepis AD
J Cardiovasc Risk; 2001 Oct; 8(5):311-7. PubMed ID: 11702038
[TBL] [Abstract][Full Text] [Related]
33. Differences in apolipoprotein (a) polymorphism in west Greenland Eskimos and Caucasian Danes.
Klausen IC; Gerdes LU; Schmidt EB; Dyerberg J; Faergeman O
Hum Genet; 1992 Jun; 89(4):384-8. PubMed ID: 1618487
[TBL] [Abstract][Full Text] [Related]
34. Combined familial hyperlipidaemia in association with apolipoprotein E3 phenotype.
Kelly JA; Robinson K; Tighe OP; Dickson B; Tomkin GH; Collins PB; Johnson AH
Biochem Soc Trans; 1990 Aug; 18(4):631. PubMed ID: 2276482
[No Abstract] [Full Text] [Related]
35. Low plasma vitamin A concentrations in familial combined hyperlipidemia.
Ribalta J; LaVille AE; Girona J; Vallvé JC; Masana L
Clin Chem; 1997 Dec; 43(12):2379-83. PubMed ID: 9439457
[TBL] [Abstract][Full Text] [Related]
36. Unrecognized dyslipoproteinemia in United Kingdom families recruited to a genetic register because of unexplained coronary heart disease.
Staunton A; Vallance DT; Child A; Camm AJ; Winder AF
J Lab Clin Med; 1994 Jun; 123(6):842-8. PubMed ID: 8201262
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein B allotypes MB19(1) and MB19(2) in subjects with coronary artery disease and hypercholesterolemia.
Young SG; Bertics SJ; Scott TM; Dubois BW; Beltz WF; Curtiss LK; Witztum JL
Arteriosclerosis; 1987; 7(1):61-5. PubMed ID: 2434069
[TBL] [Abstract][Full Text] [Related]
38. [Familial combined hyperlipidemia. I. Variation in the lipoprotein picture].
Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
Vnitr Lek; 1986 Sep; 32(9):878-86. PubMed ID: 3765425
[No Abstract] [Full Text] [Related]
39. [Combined familial hyperlipidemia. Study of a family].
Ahumada-Ayala M; Lozano-Castañeda O; Rull JA; Valles VE; Wong B
Rev Invest Clin; 1984; 36(2):141-5. PubMed ID: 6484332
[No Abstract] [Full Text] [Related]
40. Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease.
Islam S; Gutin B; Smith C; Treiber F; Kamboh MI
Arterioscler Thromb; 1994 Oct; 14(10):1609-16. PubMed ID: 7918311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
